Back to Screener

Industrials

Strata Critical Medical, Inc.(SRTAW)

Live Price

Offline

$0.035

+0.00% today

Window Change

-84.98%

Window

Aug 4, 2025 โ†’ May 18, 2026

Market Cap
$440.00M
Revenue Growth
-20.7%
EPS Growth
+242.9%
Dividend Yield
0.0%
Partial coverage

Historical coverage is still expanding

This 1Y daily history view is usable, but not fully loaded yet. Additional bars will appear as backfills continue.

Coverage: 197 bars ยท Aug 4, 2025 โ†’ May 18, 2026

Research Briefing

A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.

Decision context

Research Snapshot

Strata Critical Medical, Inc. (SRTAW) is a Industrials stock with a market cap of $440.00M and listed on NASDAQ. The stock last traded around $0.04 and down 85.0% across the available one-year price window (Aug 4, 2025 โ†’ May 18, 2026). Baseline metrics include revenue growth of -20.7%, EPS growth of +242.9%, a dividend yield of 0.0%. What stands out right now is revenue -20.7%, EPS +242.9%, free cash flow -64.8% with operating margin -11.3% and ROIC 15.8%. Valuation is more restrained than many high-expectation growth names at P/E 10.1 and price/sales 2.2. Overall, the current profile looks closer to a turnaround or cyclical reset than a generic broad-market placeholder. Stock Foundry combines SRTAW price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Industrials peers on this page.

Sector Context

How this name stacks up against nearby peers on first-pass metrics.

Revenue Growth

Below sector median

-20.7% vs +3.6% peer median

Operating Margin

Below sector median

-11.3% vs +16.9% peer median

P/E

Below sector median

10.1 vs 36.7 peer median

What Changed This Quarter

Latest report context and the signals most likely to have changed the story.

Latest report is on the board

2026 was reported on May 12, 2026, but the surprise data is still limited.

The operating picture looks softer than before

Revenue is at -20.7% and EPS is at +242.9%, with operating margin around -11.3%.

Earnings Reaction Memory

How the stock has tended to move after recent reports.

Across the last 3 reported quarters, the stock averaged -11.9% over the next 5 trading days and finished higher after 0 of those reports.

View quarter-by-quarter reaction table
QuarterEPS ฮ”1D5D20D
2026
May 12, 2026
โ€”+0.0%โ€”โ€”
2026
Mar 3, 2026
-721.4%+0.0%-12.5%-87.5%
2025
Nov 10, 2025
+1900.0%+12.5%-11.3%-12.6%

Benchmark Comparison

Normalized Performance vs SPY

Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.

1Y shared range

SRTAW

โ€”

Normalized return

SPY

โ€”

S&P 500

Excess Return

โ€”

Relative to SPY

SRTAW Max Drawdown

-98.14%

Trailing 1Y

SPY Max Drawdown

โ€”

Trailing 1Y

Benchmark comparison is loading or unavailable right now.

Calendar-Year Returns

Uses the longest available daily history for SRTAW and SPY.

Calendar-year return history is still loading or unavailable.
Strata Critical Medical, Inc. logo

Company Overview

Strata Critical Medical, Inc.

NASDAQ Global Market

Holy City Straw Company is a sustainable brand delivering 100% plant-based disposable straws and cutlery to the foodservice industry. Their products are made from natural wheat and reed plant stems, offering biodegradable and compostable alternatives to plastic straws. They focus on eco-friendly, chemical-free production with minimal carbon footprint and are USDA BioPreferred certified.

Leadership
Melissa Tomkiel
IPO Date
Aug 29, 2025
Employees
322
Street Address
31 Hudson Yards
Mailing
New York, NY, 10001
Region
New York, NY, US
Reporting Currency
USD
Investor Line
212 967 1009
Last Updated
May 5, 2026
CIK: 0001779128ISIN: US0926671126
Reports in USDSEC Registered

Key Fundamentals

Valuation, growth, profitability, and balance sheet signals.

Valuation

P/E
10.1
EV/EBITDA
โ€”
Price/Sales
2.2
Price/Book
1.5

Growth

Revenue
-20.7%
EPS
+242.9%
Free Cash Flow
-64.8%

Profitability

Gross Margin
20.9%
Operating Margin
-11.3%
Net Margin
21.0%
ROE
16.5%
ROIC
15.8%

Balance Sheet

Debt/Equity
0.01
Current Ratio
6.38

Earnings Reports

๐Ÿ“… Last reportedMay 12, 2026
PeriodB/MEPSEPS ฮ”RevenueRev ฮ”
โ€”
May 12, 26
โ€”
Est -0.04
โ€”
โ€”
Est 63674.1B
โ€”
โ€”
Mar 3, 26
โœ—
-0.06
Est 0.01
-721.4%
66787.0B
Est 60350.0B
+10.7%
โ€”
Nov 10, 25
โœ“
0.70
Est 0.03
+1900.0%
49298.0B
Est 43500.0B
+13.3%
โ€”
Aug 5, 25
โœ—
-0.05
Est -0.04
-16.7%
70801.0B
Est 64070.5B
+10.5%

Latest News

No news articles available

Official Releases

Company announcements and filings-style updates.

Official
No official releases available

Next Step

Keep the research moving

After the overview, the strongest next step is usually chart context or a tighter compare set.